AVITA Medical Inc (RCEL)
8.55
+0.25
(+3.01%)
USD |
NASDAQ |
Apr 26, 14:00
AVITA Medical Cash from Investing (TTM): 1.607M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 1.607M |
September 30, 2023 | 55.75M |
June 30, 2023 | 25.66M |
March 31, 2023 | 22.06M |
December 31, 2022 | -19.33M |
September 30, 2022 | -65.81M |
June 30, 2022 | -57.68M |
Date | Value |
---|---|
March 31, 2022 | -72.78M |
September 30, 2021 | -50.52M |
June 30, 2021 | -1.174M |
March 31, 2021 | -1.173M |
December 31, 2020 | -1.236M |
September 30, 2020 | -0.991M |
June 30, 2020 | -0.847M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-72.78M
Minimum
Mar 2022
55.75M
Maximum
Sep 2023
-11.89M
Average
-1.174M
Median
Cash from Investing (TTM) Benchmarks
Cerus Corp | 8.624M |
Elutia Inc | 14.21M |
Perspective Therapeutics Inc | 24.37M |
Xtant Medical Holdings Inc | -24.78M |
Asensus Surgical Inc | 64.51M |